Share this post on:

Product Name :

Search keywords :

drugId :

Target Vo:
Tight junction proteins

Target Vo Short Name :
Tight junction proteins

Tight junction proteins modulators

First Approval Country :

First Approval Date Filter:

Origin Company_Name :
PAI Life Sciences Inc

Active Company_Name :
Sun Yat-Sen University

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:
Ovarian Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites:
Popular product recommendations:
Bmi1 Antibody
c-Kit Antibody (YA502)
Phospho-ERK1/2 (Thr202/Thr185) Antibody: Phospho-ERK1/2 (Thr202/Thr185) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44,42 kDa, targeting to Phospho-ERK1/2 (Thr202/Thr185). It can be used for WB,IP assays with tag free, in the background of Human, Hamster, Rat.

Share this post on:

Author: Interleukin Related